Skip to main content
. 2023 May 22;15:1153251. doi: 10.3389/fnagi.2023.1153251

TABLE 4.

Demographic information of the subjects for validation.

Group ID Age Clinical diagnosis Neuropathological diagnosis PMI (h)
Middle-aged female 1 56 Squamous cell carcinoma No diagnostic abnormality 24
2 57 Cardiomyopathy Ischemic infarcts 24
3 53 Severe Anemia No diagnostic abnormality 25
4 57 Squamous cell carcinoma Cerebrovascular disease 24
5 59 Acute myeloid leukemia Cerebrovascular disease 31
Middle-aged male 6 56 Diabetes Ischemic encephalopathy 24
7 50 Coronary artery disease Cerebrovascular disease 26
8 59 Myeloproliferative neoplasms No diagnostic abnormality 19
9 50 Acute necrotizing pancreatitis Cerebrovascular disease 23
10 52 Diabetic ketoacidosis Cerebrovascular disease 20
11 42 End-stage renal disease Cerebrovascular disease 58
Aged female 12 74 Adenocarcinoma Arteriosclerosis 24
13 86 Cardiac arrest Primary age-related tauopathy 29
14 82 Myocardial infarction Primary age-related tauopathy 22
15 77 Diabetes Primary age-related tauopathy 14
16 88 Metastatic adenocarcinoma No diagnostic abnormality 7
Aged male 17 83 Adenocarcinoma Arteriosclerosis 89
18 80 Fibromuscular stroma Cerebrovascular disease 16
19 82 Cholecystitis No diagnostic abnormality 11
20 97 Multiple organ failure Cerebrovascular disease 53
21 89 Pancreatic cancer Cerebrovascular disease 22